carina

35 Years of Pioneering Pediatric Cancer Research: An Anniversary Shaping the Future (Vienna, 05.12.2023) The St. Anna Children’s Cancer Research Institute celebrates 35 years at the forefront of scientific efforts against pediatric cancer. On this anniversary, the institute granted rare insights into its laboratories, showcasing the cutting-edge research that is conducted. Afterwards, the management presented […]

Joint Effort to Fast-Track Diagnoses (Vienna, 21.11.2023) Partners from two EU-funded initiatives, the European Joint Program for Rare Diseases (EJPRD) and The European Rare Diseases Research Coordination and Support Action (ERICA), converged at a joint conference in Amsterdam. The joint conference of EJPRD and ERICA served as a critical platform for participants to explore and

3rd School of Malignant Lymphomas in Ljubljana (Vienna, 19.10.2023) The 3rd School of Malignant Lymphomas in Ljubljana recently concluded its first day, marking a significant milestone in the field of lymphoma research and diagnostics. The event featured contributions from St. Anna CCRI’s  scientists, Margarita Maurer-Granofszky and Anna-Maria Husa, who led insightful workshops focused on high-end

Childhood Cancer Awareness Month 2023 (Vienna, 01.09.2023) Throughout the year, we are committed to raising awareness about childhood cancer, which fundamentally differs from adult cancer. Every September, during Childhood Cancer Awareness Month, we think of something special to go the extra mile. This year we interviewed our young cancer researchers, delving deeper into the personal

Kaan Boztug explains defect in DOCK 11 (Vienna, 10.8.2023) Recently, Scientists from St. Anna Children’s Cancer Research Institute discovered a rare genetic defect in collaboration with the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences (ÖAW), and the Medical University of Vienna, working together with scientists from around the world. Today,

St. Anna CCRI welcomes George Cresswell as new Principal Investigator (Vienna, 01.08.2023) British bioinformatician George Cresswell has been studying various forms of childhood cancer, especially nephroblastoma, since his student days. As Principal Investigator at St. Anna Children’s Cancer Research Institute, he will turn his attention to the evolutionary biology of cancer cells in an attempt

Sarcoma Awareness Month: exposing an insidious Nemesis (Vienna, 27.07.2023) Sarcomas pose a significant challenge, especially for children and adolescents, as the tumors often go undetected and metastasize. At St. Anna Children’s Cancer Research Institute, two research groups are dedicated to studying this tumor. Sarcomas are rare forms of cancer, comprising only two percent of all

“I wish you the best of luck and groundbreaking research results!” (Vienna, 24.07.2023) Bestselling author Ursula Poznanski in brief: Why she supports the St. Anna Children’s Cancer Research Institute, how she deals with criticism, and what her best decision was! Under the motto of our 35th anniversary “Reaching for the stars”, we interviewed exciting, renowned

Successful ERNPaedCan General Assembly (Vienna, 30.06.2023) The St. Anna CCRI team, in collaboration with SIOPE, successfully coordinated this year’s General Assembly for the ERN PaedCan project, marking five years of significant achievements. The assembly functioned as platform to celebrate the progress made and to examine the benefits delivered to patients through the network’s activities. The

Neuroblastoma Dialogue at ANR Meeting in Amsterdam (Vienna, 26.05.2023) At last week’s Advances in Neuroblastoma Research (ANR) Meeting in Amsterdam, St. Anna CCRI had a strong presence contributing with remarkable talks and posters. Florian Halbritter captivated the audience with his insightful talk on their study titled “Neuroblastoma-associated chromosomal aberrations drive cell identity loss in human neural

Top Talk of the API Conference (Vienna, 19.05.2023) Artem Kalinichenko won the prize for the best talk at the recent API in Germany. His presentation on a genome-wide CRISPR screening approach to identify and study key factors essential for human lymphocyte function stood out for its groundbreaking insights. API (Arbeitsgemeinschaft Pädiatrische Immunologie) is an esteemed

CLLS 2023 Symposium: Advancements in Childhood Leukemia and Lymphoma Research (Vienna, 07.05.2023) The 13th Biennial Childhood Leukemia and Lymphoma Symposium (CLLS) unfolded in Valencia, where St. Anna CCRI, Labdia, and St. Anna Children’s Hospital actively participated. CLLS is a pivotal platform for fellows, researchers, and junior faculty to share groundbreaking insights into malignant hematological malignancies,

Natural Killer Cell Symposium in Krems (Krems, 04.05.2023) The NK Cell Symposium in Krems was a pivotal gathering spotlighting the role of natural killer (NK) cells in cancer immunotherapy. Researchers from the St. Anna CCRI and other institutions shared their latest findings, emphasizing NK cells’ potential as a powerful tool in combating cancer. The NK

From Now to NEXT: AI-Driven Neuroblastoma Diagnostics (Vienna, 25.04.2023) A follow-up project, aiming to address the urgent need for advanced diagnostic tools in ultra-high-risk pediatric cancer research was funded by the WWTF NEXT Call. By developing a web-based app, Sabine Taschner-Mandl seeks to empower diagnostic laboratories to conduct tests independently, enhancing the precision and speed

Instand–NGS4P General Assembly (Vienna, 30.03.2023) St. Anna CCRI was recognized in the January edition of the Organization of European Cancer Institute’s Newsletter. This newsletter featured St. Anna CCRI as the exclusive childhood oncology partner in the Instand-NGS4P project. Leveraging this early recognition, the team, led by the Scientific Director Kaan Boztug and Ruth Ladenstein, actively